Document is current
Any future updates will be listed below
-
Authors
Xie, Tingting
Wang, Guangya http://orcid.org/0000-0002-8482-1556
Ding, Spencer C. http://orcid.org/0000-0002-7244-5995
Lee, Wing-Shan
Cheng, Suk Hang http://orcid.org/0000-0002-2880-2289
Chan, Rebecca W. Y. http://orcid.org/0000-0002-5202-4210
Zhou, Ze
Ma, Mary-Jane L.
Han, Diana S. C.
Teoh, Jeremy Y. C.
Lam, W. K. Jacky
Jiang, Peiyong http://orcid.org/0000-0003-4523-3476
Chiu, Rossa W. K.
Chan, K. C. Allen
Lo, Y. M. Dennis http://orcid.org/0000-0001-8746-0293
-
Funding
Funding for this research was provided by:
Chinese University of Hong Kong (VCF2014021, VCF2014021, VCF2014021, VCF2014021)
an endowed chair from the Li Ka Shing Foundation
Research Grants Council, University Grants Committee (T12-401/16-W, T12-401/16-W, T12-401/16-W)
- License Information
-
More Information
Article History
Received: 20 September 2021
Accepted: 22 December 2021
First Online: 23 February 2022
Competing interests
: K.C.A.C., R.W.K.C., and Y.M.D.L. hold equities in DRA, Take2, and Grail/Illumina. K.C.A.C., R.W.K.C., and Y.M.D.L. were consultants to Grail. K.C.A.C., R.W.K.C., and Y.M.D.L. had received research funding from Grail. Y.M.D.L. is a scientific cofounder of and serves on the scientific advisory board of Grail. R.W.K.C. is a consultant to Illumina. W.K.J.L. and P.J. hold equities in Grail/Illumina. P.J. hold equities in DRA. P.J. is a consultant to Take2. P.J. is a Director of KingMed Future. T.X., G.W., S.C.D., P.J., S.H.C., Z.Z., K.C.A.C., R.W.K.C., and Y.M.D.L. have filed patent applications based on the data generated from this work. Patent royalties are received from Grail, Illumina, Sequenom, DRA, Take2, and Xcelom. Y.M.D.L. is an Associate Editor for npj Genomic Medicine.
